449758-31-0

Basic information

• Product Name: 5-CHLORO-2-(1H-1,2,4-TRIAZOL-1-YL)BENZONITRILE
• Synonyms: 5-CHLORO-2-(1H-1,2,4-TRIAZOL-1-YL)BENZONITRILE
• CAS NO: 449758-31-0
• Molecular Formula: C₉H₅ClN₄
• Molecular Weight: 204.62
• Mol File: 449758-31-0.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-CHLORO-2-(1H-1,2,4-TRIAZOL-1-YL)BENZONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-CHLORO-2-(1H-1,2,4-TRIAZOL-1-YL)BENZONITRILE(449758-31-0)
• EPA Substance Registry System: 5-CHLORO-2-(1H-1,2,4-TRIAZOL-1-YL)BENZONITRILE(449758-31-0)

Safety Data

• Hazardous Substances Data: 449758-31-0(Hazardous Substances Data)

Upstream product

• 288-88-0 1,2,4-Triazole 
• 21663-61-6 2,5-dichlorobenzonitrile 

Downstream Products

• 629655-19-2 5-chloro-2-(1H-1,2,4-triazol-1-yl)benzoic acid 
• 404922-72-1 5-Chloro-2-[1,2,4]triazol-1-yl-benzylamine 
• 629655-38-5 tert-butyl 2-(2-{[3-({[5-chloro-2-(1H-1,2,4-triazol-1-yl)phenyl]acetyl}amino)-4-hydroxypyridin-2-yl]amino}ethyl)piperidine-1-carboxylate 
• 629655-39-6 tert-butyl 2-[2-({2-[5-chloro-2-(1H-1,2,4-triazol-1-yl)benzyl][1,3]oxazolo[4,5-c]pyridin-4-yl}amino)ethyl]piperidine-1-carboxylate 
• 629655-21-6 2-(1,2,4-triazol-1-yl)-5-chlorophenylacetic acid 
• 629655-20-5 [5-chloro-2-(1H-1,2,4-triazol-1-yl)phenyl]acetonitrile 
• 404922-80-1 1-[2-(bromomethyl)-4-chlorophenyl]-1H-1,2,4-triazole 
• 404922-74-3 [5-chloro-2-(1H-1,2,4-triazol-1-yl)phenyl]methanol 

Relevant articles and documents

Benzimidazole derivative and pharmaceutical purposes thereof

The invention discloses a benzimidazole derivative and pharmaceutical purposes thereof, and particularly discloses a benzimidazole derivative shown in a formula I and purposes of the benzimidazole derivative to preparation of drugs for treating and/or pre

DPP-IV INHIBITORS

The invention relates to compounds of formula (I), Z-C(R1R 2)-C(R3NH2)-C(R4R5)-X-N(R 6R7), wherein Z, R1-7 and X have the meaning as cited in the description and the claims. Said compounds are useful as DPP-lV inhibitors. The invention also relates to the

Thrombin inhibitors

Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: or a pharmaceutically acceptable salt thereof.